Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
Ramina Fazeli, Medical Doctor at Alborz University of Medical sciences, shared a post on LinkedIn about a recent article she and her collegues co-authored, published in adding:
“This review highlights the emerging role of neutrophil extracellular traps (NETs) in ovarian cancer progression, tumor microenvironment remodeling, immune evasion, angiogenesis, and therapeutic resistance.
We also discussed the molecular pathways involved in NETosis and explored the potential of NET-targeted therapies as promising strategies to improve treatment response and patient outcomes in ovarian cancer.
I am grateful to all co-authors and collaborators for their valuable contributions to this work.
I hope this article adds to the growing understanding of the complex interactions between inflammation, immunity, and cancer biology.”
Title: The neutrophil–NET Axis in ovarian cancer: Drivers of tumor microenvironment remodeling and therapeutic resistance
Authors: Hoda Zendehdel, Mahsa Esgandari, Paria Panahinia, Ramina Fazeli, Atoosa Etezadi, Sania Rahimi

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research